Researchers are testing whether transferring healthy oral bacteria from donors can rebalance the oral microbiome and provide a breakthrough treatment for chronic oral malodor.
Read More...
How Community-Based Dental Residencies Are Expanding Access to Care
Federal investments in community-based dental residency programs are creating a new generation of dentists prepared to serve rural,…
The Esther Wilkins Lifetime Achievement Award Honors Icon in Dental Hygiene…
Educator, mentor, scholar, and innovator, Cynthia C. Gadbury-Amyot, RDH, MS, EdD, FADHA, transformed dental hygiene education and…
Why Routine Patient Shielding May No Longer Be Necessary
Advances in digital imaging, rectangular collimation, and modern radiation science are challenging decades-old shielding practices.
Rice University Students Harness AI to Transform the Front Desk
A student-founded startup is helping dental practices streamline scheduling, insurance verification, and patient communication with…
Weekly Popular
Personal Finance
More Top Stories
Federal Safety Standard Closes the Gap in Eyewear Protection
According to the United States Centers for Disease Control and Prevention, about 2,000 US workers sustain a job-related eye injury each day that requires medical treatment. This includes oral health professionals, who are subject to…
Will Telehealth Be the Answer to Rising Pandemic-Related Mental Health Issues?
According to a study in The Lancet, COVID-19 brought more than viral illness, lockdowns, and business disruptions, it also led to an increase in mental health problems. Researchers reported 76 million more cases of anxiety disorders and 53…
Presence of Gene Increases Risk of Severe COVID-19 Illness
One of the most significant unanswered questions of the global pandemic is why some people experience mild symptoms while others become seriously ill and even die. The answer may be in our genes. Researchers from the United Kingdom have…
Pfizer to Seek FDA Approval for Its COVID-19 Antiviral Medication
On the heels of the United Kingdom’s authorization of a competing medication by Merck, Pfizer announced that its own antiviral drug designed to treat COVID-19 shows promising results. According to the company’s clinical trial on 775 adults…
UK Approves Use of Antiviral Medication to Treat COVID-19
The United Kingdom (UK) has authorized the use of an antiviral medication, molnupiravir, to reduce the severity of illness associated with COVID-19. Manufactured by the American pharmaceutical company, Merck, molnupiravir has been shown to…
Is COVID-19 Switching From Pandemic to Endemic?
Many public health experts suggest that the COVID-19 pandemic will come to a close by the end of 2022, and while it will not disappear, the pandemic will mutate into an endemic disease. This change will mean that most people will have…
Pending Legislation Promotes Oral Health Literacy
Federal legislation of interest to the oral health community was recently included in a hearing held by the U.S. House of Representatives’ Energy and Commerce Committee: the Oral Health Literacy and Awareness Act of 2021 (H.R. 4555).…
The Demographics of COVID-19 Continue to Evolve
At the start of the COVID-19 pandemic, it was clear who was at greatest risk for COVID-19-related mortality and morbidity—older adults and those with preexisting conditions such as diabetes, and where—urban centers with dense populations in…
A Sad COVID-19 Milestone Reached: 5 Million People Dead
While the United States is experiencing a much-needed slow down in the number of new COVID-19 cases across the country, a tragic milestone has been met—throughout the globe, more than 5 million people have died due to illness caused by …
New Colgate® Optic White® Professional
New Colgate® Optic White® Professional is extraordinary whitening made simple. Help patients achieve a dramatically whiter smile in just 5 days, when used as directed. ALL-NEW patented technology designed for no tooth sensitivity, no gum…
Recent Posts
Market Media
- Advertisement -
